首页> 美国卫生研究院文献>other >Enzymatic Characterization of ER Stress-Dependent Kinase PERK and Development of a High-Throughput Assay for Identification of PERK Inhibitors
【2h】

Enzymatic Characterization of ER Stress-Dependent Kinase PERK and Development of a High-Throughput Assay for Identification of PERK Inhibitors

机译:ER应力依赖性激酶PERK的酶学表征以及鉴定PERK抑制剂的高通量检测方法的发展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PERK is serine/threonine kinase localized to the endoplasmic reticulum (ER) membrane. PERK is activated and contributes to cell survival in response to a variety of physiological stresses that affect protein quality control in the ER, such as hypoxia, glucose depravation, increased lipid biosynthesis, and increased protein translation. Pro-survival functions of PERK are triggered by such stresses, suggesting that development of small-molecule inhibitors of PERK may be efficacious in a variety of disease scenarios. Hence, we have conducted a detailed enzymatic characterization of the PERK kinase to develop a high-throughput-screening assay (HTS) that will permit the identification of small-molecule PERK inhibitors. In addition to establishing the Km of PERK for both its primary substrate, eIF2α, and for adenosine triphosphate, further mechanistic studies revealed that PERK targets its substrate via either a random/steady-state ordered mechanism. For HTS, we developed a time-resolved fluorescence resonance energy transfer–based assay that yielded a robust Z′ factor and percent coefficient of variation value, enabling the successful screening of 79,552 compounds. This approach yielded one compound that exhibited good in vitro and cellular activity. These results demonstrate the validity of this screen and represent starting points for drug discovery efforts.
机译:PERK是位于内质网(ER)膜上的丝氨酸/苏氨酸激酶。 PERK被激活并响应各种影响ER中蛋白质质量控​​制的生理压力,例如缺氧,葡萄糖下降,脂质生物合成增加和蛋白质翻译增加,从而促进细胞存活。这种压力触发了PERK的生存功能,这表明PERK的小分子抑制剂的开发在多种疾病中可能是有效的。因此,我们已经对PERK激酶进行了详细的酶学表征,以开发高通量筛选测定(HTS),从而可以鉴定小分子PERK抑制剂。除了确定其主要底物eIF2α和三磷酸腺苷的PERK的Km之外,进一步的机理研究还显示,PERK通过随机/稳态有序机制靶向其底物。对于HTS,我们开发了一种基于时间分辨荧光共振能量转移的测定方法,该方法产生了稳健的Z'因子和变异系数百分比值,从而能够成功筛选79,552种化合物。该方法产生了一种表现出良好的体外和细胞活性的化合物。这些结果证明了该筛选的有效性,并代表了药物发现工作的起点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号